Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents

Publication Date: June 4, 2019
Last Updated: December 15, 2022

Treatment

Depending on clinical circumstances ESAs may be offered to patients with chemotherapy-associated anemia whose cancer treatment is not curative in intent and whose hemoglobin has declined to <10 g/dL. Red blood cell transfusion is also an option, depending on the severity of the anemia or clinical circumstances. ( EB , H , S )
6539

Overview

Title

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents

Authoring Organization